Cart
sales@molnova.com
Tripelennamine hydrochloride
CAS No. 154-69-8
Tripelennamine hydrochloride( Pyribenzamine hydrochloride )
Catalog No. M12195 CAS No. 154-69-8
A first-generation antihistamine that acts primarily as H1 receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 32 | In Stock |
|
| 500MG | 60 | In Stock |
|
| 1G | 91 | In Stock |
|
Biological Information
-
Product NameTripelennamine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA first-generation antihistamine that acts primarily as H1 receptor antagonist.
-
DescriptionA first-generation antihistamine that acts primarily as H1 receptor antagonist; has little or no anticholinergic activity, also acts as a weak serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).Asthma Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsPyribenzamine hydrochloride
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1receptor
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number154-69-8
-
Formula Weight291.819
-
Molecular FormulaC16H22ClN3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 33 mg/mL
-
SMILESCl.CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1
-
Chemical Name1,2-Ethanediamine, N1,N1-dimethyl-N2-(phenylmethyl)-N2-2-pyridinyl-, hydrochloride (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Oishi R, et al. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):140-4.
2. Sato T, et al. Jpn J Pharmacol. 1996 May;71(1):81-4.
3. Yeh SY, et al. Synapse. 1999 Sep 1;33(3):207-17.
molnova catalog
related products
-
Guaiazulene
Guaiazulene belongs to the class of organic compounds known as guaianes.
-
SUVN-G3031 dihydroch...
SUVN-G3031 (SUVN-G 3031) is a potent, selective, orally active histamine H3 receptor (H3R) inverse agonist with Ki of 8.73 nM (hH3R).
-
Bavisant
Bavisant is a selective and orally active Human H3 receptor antagonist. Bavisant can be used in research on mechanisms of action, involving wakefulness and cognition and the treatment for ADHD.
